Record NNP B-NP O
date NN I-NP O
: : O O
2077-11-16 CD O B-DATE
Educare-Fargo NNP B-NP B-HOSPITAL
E NNP I-NP O
Admission NNP I-NP O
Note NN I-NP O
PATIENT NNP B-NP O
: : O O
Rebecca NN B-NP B-PATIENT
Carlson NNP I-NP I-PATIENT
MRN NNP B-NP O
: : O O
9500004 CD O B-MEDICALRECORD
ADMIT NNP B-NP O
DATE NNP I-NP O
: : O O
11/14/2077 CD O B-DATE
Transfer NN B-NP O
to TO B-PP O
Team NNP B-NP O
E NNP I-NP O
Date NNP I-NP O
: : O O
11/16/2077 CD O B-DATE
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
James NNP I-NP B-DOCTOR
Colton NNP I-NP I-DOCTOR
Yancey NNP I-NP I-DOCTOR
ATTENDING VBG B-NP O
PHYSICIAN NNP I-NP O
: : O O
Dr. NNP B-NP O
Ila NNP I-NP B-DOCTOR
Araujo NNP I-NP I-DOCTOR
CHIEF NNP B-NP O
COMPLAINT NNP I-NP O
Fall NN B-NP O
HISTORY NN B-NP O
OF IN B-PP O
THE DT B-NP O
PRESENT JJ I-NP O
ILLNESS NNS I-NP O
Pt NNP B-NP O
is VBZ B-VP O
an DT B-NP O
88 CD I-NP B-AGE
yo NNP I-NP O
woman NN I-NP O
with IN B-PP O
a DT B-NP O
PMH NNP I-NP O
of IN B-PP O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
mild JJ B-NP O
dementia NN I-NP O
and CC I-NP O
baseline NN I-NP O
anxiety NN I-NP O
with IN B-PP O
a DT B-NP O
hx NN I-NP O
of IN B-PP O
falls NNS B-NP O
who WP B-NP O
was VBD B-VP O
admitted VBN I-VP O
following VBG I-VP O
a DT B-NP O
witnessed VBN I-NP O
mechanical JJ I-NP O
fall NN I-NP O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
a DT B-NP O
Type JJ I-NP O
III NNP I-NP O
dens NNS I-NP O
fracture NN I-NP O
and CC I-NP O
R NN I-NP O
superior/inferior JJ I-NP O
pubic JJ I-NP O
ramus NN I-NP O
fracture NN I-NP O
. . O O
She PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
by IN B-PP O
ortho NNP B-NP O
, , O O
and CC O O
they PRP B-NP O
recommended VBD B-VP O
use NN B-NP O
of IN B-PP O
an DT B-NP O
Aspen JJ I-NP O
collar NN I-NP O
for IN B-PP O
the DT B-NP O
dens NNS I-NP O
fracture NN I-NP O
, , O O
and CC O O
no DT B-NP O
operative JJ I-NP O
management NN I-NP O
for IN B-PP O
the DT B-NP O
pubic JJ I-NP O
ramus NN I-NP O
fracture NN I-NP O
. . O O
On IN B-PP O
11/15 CD B-NP B-DATE
, , O O
patient NN B-NP O
was VBD B-VP O
noted VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
decreased VBN I-NP O
Hct NNP I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
attributed VBN I-VP O
to TO B-PP O
an DT B-NP O
expanding VBG I-NP O
hematoma NN I-NP O
on IN B-PP O
her PRP$ B-NP O
right JJ I-NP O
thigh NN I-NP O
, , O O
and CC O O
she PRP B-NP O
was VBD B-VP O
given VBN I-VP O
2 CD B-NP O
U NNP I-NP O
of IN B-PP O
PRBCs NNP B-NP O
from IN B-PP O
9:30am-5pm JJ B-NP O
on IN B-PP O
11/15 CD B-NP B-DATE
. . O O
Overnight NNP O O
her PRP B-NP O
O2 NNP B-NP O
requirement NN I-NP O
increased VBD B-VP O
from IN B-PP O
2L JJ B-ADJP O
to TO B-VP O
4L VB I-VP O
, , O O
and CC O O
she PRP B-NP O
was VBD B-VP O
given VBN I-VP O
Lasix NNP B-NP O
in IN B-PP O
response NN B-NP O
to TO B-PP O
a DT B-NP O
chest NN I-NP O
X-ray NN I-NP O
which WDT B-NP O
showed VBD B-VP O
signs NNS B-NP O
of IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
. . O O
Throughout IN B-PP O
the DT B-NP O
day NN I-NP O
patient NN I-NP O
became VBD B-VP O
progressively RB B-ADJP O
more JJR I-ADJP O
agitated JJ I-ADJP O
, , O O
and CC O O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
her PRP$ B-NP O
standing NN I-NP O
Seroquel NNP I-NP O
( -LRB- I-NP O
12.5 CD I-NP O
mg JJ I-NP O
bid NN I-NP O
) -RRB- I-NP O
, , O O
she PRP B-NP O
was VBD B-VP O
also RB I-VP O
given VBN I-VP O
two CD B-NP O
doses NNS I-NP O
of IN B-PP O
Zyprexa NNP B-NP O
( -LRB- I-NP O
2.5mg JJ I-NP O
and CC I-NP O
5mg JJ I-NP O
) -RRB- I-NP O
. . O O
Overnight NNP B-NP O
on IN B-PP O
11/15 CD B-NP B-DATE
- : O O
11/16 CD B-NP B-DATE
she PRP B-NP O
became VBD B-VP O
febrile JJ B-ADJP O
, , O O
up RB B-ADVP O
to TO B-PP O
103.5 CD B-NP O
, , O O
peaking VBG B-VP O
at IN B-PP O
105.6 CD B-NP O
in IN B-PP O
the DT B-NP O
morning NN I-NP O
on IN B-PP O
11/16 CD B-NP B-DATE
, , O O
despite IN B-PP O
standing VBG B-NP O
Tylenol NNP I-NP O
. . I-NP O
Blood NNP I-NP O
cultures NNS I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
were VBD B-VP O
taken VBN I-VP O
, , O O
and CC O O
patient NN B-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
Levoquin NNP B-NP O
, , I-NP O
Vancomycin NNP I-NP O
and CC I-NP O
Ceftriaxone NNP I-NP O
, , O O
and CC O O
transferred VBD B-VP O
to TO B-PP O
Team NNP B-NP O
E. NNP I-NP O
REVIEW NN B-NP O
OF IN B-PP O
SYSTEMS NNP B-NP O
Per NNP B-NP O
HPI NNP I-NP O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NN I-NP O
DM NNP B-NP O
&#8211 CD I-NP O
; : O O
diet NN B-NP O
controlled VBN I-NP O
HTN . O O
Hypothyroidism NN B-NP O
Hx NNP B-NP O
of IN B-PP O
post-op JJ B-NP O
DVT NNP I-NP O
( -LRB- I-NP O
&gt NN I-NP O
;40 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
after IN B-PP O
a DT B-NP O
hysterectomy NN I-NP O
) -RRB- O O
Fall NNP B-NP O
with IN B-PP O
L NNP B-NP O
hip NN I-NP O
fracture NN I-NP O
, , O O
s/p NN B-NP O
hemiarthroplasty NN I-NP O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY NN I-NP O
Hysterectomy NN B-NP O
L NNP B-NP O
hemiarthroplasty NN I-NP O
RECENT NNP B-NP O
DIAGNOSTIC NNP I-NP O
STUDIES NNS I-NP O
TTE NN B-NP O
( -LRB- I-NP O
11/77 CD I-NP B-DATE
) -RRB- O O
Moderate NNP B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
no DT B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
, , O O
trace NN B-NP O
regurgitation NN I-NP O
. . O O
Estimated VBN B-VP O
EF NNP B-NP O
78 CD I-NP O
% NN I-NP O
. . O O
Moderate NNP O O
to TO B-PP O
severe JJ B-NP O
tricuspid JJ I-NP O
insufficiency NN I-NP O
. . O O
RVSP '' O O
56 CD B-NP O
mmHg NN I-NP O
FAMILY NNP B-NP O
HISTORY NN I-NP O
Maternal NNP B-NP O
&#8211 CD I-NP O
; : O O
3 CD B-NP O
MIs NN I-NP O
Paternal NNP B-NP O
&#8211 CD I-NP O
; : O O
Hx NNP B-NP O
of IN B-PP O
open JJ B-NP O
heart NN I-NP O
surgery NN I-NP O
( -LRB- B-VP O
? . B-NP O
valvular JJ I-NP O
disease NN I-NP O
) -RRB- O O
Siblings NNP B-NP O
&#8211 CD I-NP O
; : O O
One CD B-NP O
brother NN I-NP O
with IN B-PP O
lung NN B-NP O
cancer NN I-NP O
Children NNS B-NP O
&#8211 CD B-NP O
; : O O
1 CD B-NP O
son NN I-NP O
and CC O O
2 CD B-NP O
daughters NNS I-NP O
, , O O
all DT B-NP O
very RB I-NP O
supportive JJ I-NP O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
General NNP B-NP O
&#8211 CD I-NP O
; : O O
Pt NNP B-NP O
lives VBZ B-VP O
by IN B-PP O
herself PRP B-NP O
on IN B-PP O
the DT B-NP O
third JJ I-NP O
floor NN I-NP O
of IN B-PP O
a DT B-NP O
house NN I-NP O
, , O O
with IN B-PP O
her PRP$ B-NP O
daughter NN I-NP O
and CC I-NP O
son NN I-NP O
on IN B-PP O
the DT B-NP O
2nd NNP I-NP O
and CC I-NP O
1st JJ I-NP O
floors NNS I-NP O
of IN B-PP O
the DT B-NP O
building NN I-NP O
. . O O
One CD B-NP O
of IN B-PP O
her PRP$ B-NP O
children NNS I-NP O
is VBZ B-VP O
usually RB B-ADVP O
with IN B-PP O
her PRP B-NP O
at IN B-PP O
all DT B-NP O
times NNS I-NP O
. . O O
Tobacco NNP B-NP O
&#8211 NNP I-NP O
; : O O
The DT B-NP O
patient NN I-NP O
denies VBZ B-VP O
tobacco NN B-NP O
use NN I-NP O
. . O O
Alcohol NNP B-NP O
&#8211 NNP I-NP O
; : O O
The DT B-NP O
patient NN I-NP O
denies VBZ B-VP O
recent JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
. . O O
Illicit NNP B-NP O
drugs NNS I-NP O
&#8211 NNP I-NP O
; : O O
The DT B-NP O
patient NN I-NP O
denies VBZ B-VP O
past JJ B-ADJP O
and CC O O
present JJ B-NP O
use NN I-NP O
of IN B-PP O
illicit JJ B-NP O
drugs NNS I-NP O
. . O O
ALLERGIES/ADVERS NNP B-NP O
E NNP I-NP O
REACTIONS NNS I-NP O
HCTZ NNP B-NP O
&#8211 CD I-NP O
; : O O
unknown JJ B-NP O
reaction NN I-NP O
MEDICATIONS NNS B-NP O
ON IN B-PP O
ADMISSION NN B-NP O
1 LS O O
. . B-NP O
Acetylsalicylic NNP I-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Aspirin NN I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
2. CD B-NP O
Amlodipine NNP I-NP O
( -LRB- I-NP O
Norvasc NNP I-NP O
) -RRB- I-NP O
7.5 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QD . O O
3. . B-NP O
Atenolol NNP I-NP O
75 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS . O O
4 CD B-NP O
. . O O
Atorvastatin NNP O O
( -LRB- O O
Lipitor NN B-NP O
) -RRB- I-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
5 CD B-NP O
. . O O
Calcium NNP B-NP O
Carbonate/Vitd NNP I-NP O
( -LRB- I-NP O
250mg JJ I-NP O
Ca++/125u NN I-NP O
Vitd NNP I-NP O
) -RRB- I-NP O
1 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
QD . O O
6 CD B-NP O
. . O O
Docusate NNP B-NP O
Sodium NNP I-NP O
( -LRB- I-NP O
Colace NN I-NP O
) -RRB- I-NP O
100 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
7. . B-NP O
Ferrous NNP I-NP O
Sulfate NNP I-NP O
325 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
8. CD B-NP O
Furosemide NNP I-NP O
( -LRB- I-NP O
Lasix NNP I-NP O
) -RRB- I-NP O
Variable NNP I-NP O
PO NNP I-NP O
QD . O O
120 CD B-NP O
mg NN I-NP O
qAM NNP B-NP O
and CC O O
80 CD B-NP O
mg JJ I-NP O
qpm NN I-NP O
9 CD B-NP O
. . I-NP O
Levothyroxine NNP I-NP O
Sodium NNP I-NP O
( -LRB- I-NP O
Levothroid NNP I-NP O
) -RRB- I-NP O
25 CD I-NP O
MCG NNP I-NP O
PO NNP I-NP O
QD . O O
10 CD B-NP O
. . I-NP O
Quetiapine NNP I-NP O
( -LRB- O O
Seroquel NN B-NP O
) -RRB- I-NP O
12.5 CD I-NP O
PO NNP I-NP O
BID NNP I-NP O
11 CD B-NP O
. . O O
Sennosides NNS B-VP O
( -LRB- B-NP O
Senna NNP I-NP O
Tablets NNP I-NP O
) -RRB- I-NP O
2 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
QD . O O
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
VITALS NNS B-NP O
: : O O
T NNP B-NP O
104.5 CD I-NP O
P NNP I-NP O
102 CD I-NP O
BP NNP B-NP O
144/78 CD I-NP O
RR IN B-PP O
50 CD B-NP O
SaO2 JJ I-NP O
92 CD I-NP O
% NN I-NP O
on IN B-PP O
6L JJ B-NP O
NC NNP I-NP O
General NNP B-NP O
&#8211 CD I-NP O
; : O O
female NN B-NP O
lying VBG I-NP O
in IN B-PP O
bed NN B-NP O
, , O O
occasionally RB B-ADVP O
moaning VBG B-NP O
, , O O
shaking VBG B-VP O
all DT B-NP O
extremities NNS I-NP O
, , O O
C-collar NN B-NP O
in IN B-PP O
place NN B-NP O
HEENT NNP B-NP O
&#8211 CD I-NP O
; : O O
normocephalic JJ B-NP O
, , I-NP O
atraumatic JJ I-NP O
; : O O
PERRL NNP B-NP O
, , O O
EOMI NNP B-NP O
; : O O
sclerae NNS B-NP O
anicteric NN I-NP O
, , O O
no DT B-NP O
conjunctival NN I-NP O
injection NN I-NP O
; : O O
oropharynx NNP B-NP O
pink JJ I-NP O
and CC I-NP O
moist JJ I-NP O
without IN B-PP O
erythema NN B-NP O
, , O O
exudates NNS B-NP O
, , O O
or CC O O
lesions NNS B-NP O
Neck NNP B-NP O
- : O O
no DT B-NP O
lymphadenopathy NN I-NP O
, , O O
normal JJ B-NP O
thyroid NN I-NP O
without IN B-PP O
masses NNS B-NP O
; : O O
JVP JJ B-NP O
flat JJ I-NP O
; : O O
carotid JJ B-NP O
pulses NNS I-NP O
2+ VBP B-VP O
bilaterally RB B-ADVP O
; : O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
; : O O
the DT B-NP O
trachea NN I-NP O
is VBZ B-VP O
midline NN O O
Pulmonary JJ B-NP O
&#8211 CD I-NP O
; : O O
slight JJ B-NP O
crackles NNS I-NP O
at IN B-PP O
both DT B-NP O
bases NNS I-NP O
Cardiac NNP B-NP O
&#8211 CD I-NP O
; : O O
tachycardic NN B-NP O
; : O O
S1 NNP B-NP O
and CC I-NP O
S2 NNP I-NP O
normal JJ I-NP O
; : O O
no DT B-NP O
murmurs NNS I-NP O
, , I-NP O
rubs NNS I-NP O
or CC I-NP O
gallops NNS I-NP O
; : O O
2+pulses NNS B-NP O
in IN B-PP O
the DT B-NP O
extremities NNS I-NP O
bilaterally RB B-LST O
Abdomen NNP B-NP O
&#8211 CD I-NP O
; : O O
soft JJ B-NP O
, , I-NP O
non-distended JJ I-NP O
; : O O
non-tender JJ B-ADJP O
without IN B-PP O
rebound NN B-VP O
and CC I-VP O
guarding VBG I-VP O
; : O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
; : O O
no DT B-NP O
masses NNS I-NP O
or CC I-NP O
hepatosplenomegaly NN I-NP O
Extremity NN B-NP O
&#8211 CD I-NP O
; : O O
warm JJ B-NP O
and CC I-NP O
well-perfused JJ I-NP O
; : O O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
or CC O O
edema NN B-NP O
Neurology NNP B-NP O
&#8211 CD I-NP O
; : O O
Pt NNP B-NP O
intermittently RB B-ADVP O
responds VBZ B-VP O
to TO I-VP O
voice VB I-VP O
, , O O
unable JJ B-ADJP O
to TO B-VP O
follow VB I-VP O
commands NNS B-NP O
. . O O
Alternates NNP O O
between IN B-PP O
severe JJ B-NP O
rigidity NN I-NP O
and CC O O
extreme JJ B-NP O
flaccidity NN I-NP O
. . O O
She PRP B-NP O
will MD B-VP O
retract VB I-VP O
from IN B-PP O
pain NN B-NP O
intermittently RB B-ADVP O
, , O O
seemingly RB B-ADVP O
more RBR I-ADVP O
often RB I-ADVP O
with IN B-PP O
L NNP B-NP O
leg NN I-NP O
and CC I-NP O
R NN I-NP O
arm NN I-NP O
. . O O
Skin NNP B-NP O
&#8211 CD I-NP O
; : O O
large JJ B-NP O
hematoma NN I-NP O
on IN B-PP O
R NN B-NP O
hip NN I-NP O
Mental JJ B-NP O
status NN I-NP O
&#8211 NNS I-NP O
; : O O
alert JJ B-NP O
and CC I-NP O
oriented JJ I-NP O
x NN I-NP O
3 CD O O
LABORATORIES NNS B-NP O
11/16/77 CD B-NP B-DATE
11/16/77 CD I-NP B-DATE
11/16/77 CD I-NP B-DATE
11/15/77 CD O B-DATE
14:24 CD B-NP O
11:41 CD I-NP O
05 CD I-NP O
:05 IN B-PP O
03 CD B-NP O
:58 CD I-NP O
NA NNP B-NP O
143 CD I-NP O
141 CD I-NP O
138 CD O O
K NNP B-NP O
2.9( JJ I-NP O
L NNP I-NP O
) -RRB- I-NP O
3.8 CD I-NP O
3.4 CD O O
CL NN B-NP O
100 CD I-NP O
101 CD I-NP O
100 CD I-NP O
CO2 NNP B-NP O
27.5 CD I-NP O
28.9 CD I-NP O
30.7 CD O O
BUN NNP B-NP O
25 CD B-NP O
21 CD I-NP O
18 CD O O
CRE NNP B-NP O
1.24 CD I-NP O
1.11 CD I-NP O
0.88 CD O O
EGFR NN B-NP O
43( JJ B-NP O
T NNP I-NP O
) -RRB- I-NP O
49( JJ I-NP O
T NNP I-NP O
) -RRB- I-NP O
&gt , O O
;60( JJ B-NP O
T NNP I-NP O
) -RRB- O O
GLU . O O
205( CD B-NP O
H) NN I-NP O
227( CD B-NP O
H) NN I-NP O
164( CD B-NP O
H) NN I-NP O
169( CD B-NP O
H) NN I-NP O
ANION NNP B-NP O
16( CD I-NP O
H) NNP I-NP O
11 CD I-NP O
7 CD I-NP O
CA NNP B-NP O
8.3( JJ I-NP O
L NNP I-NP O
) -RRB- I-NP O
8.7 CD I-NP O
8.4( JJ I-NP O
L NNP I-NP O
) -RRB- O O
PHOS NNS B-NP O
2.2( JJ B-NP O
L NNP I-NP O
) -RRB- I-NP O
2.2( JJ I-NP O
L NNP I-NP O
) -RRB- O O
MG NNP B-NP O
1.5 CD I-NP O
1.6 CD O O
TBILI . O O
1.4( CD B-NP O
H) NN I-NP O
DBILI . O O
0.5( CD B-NP O
H) NN I-NP O
TP NNP B-NP O
6.9 CD I-NP O
ALB NNP B-NP O
3.5 CD I-NP O
GLOB NNP B-NP O
3.4 CD I-NP O
ALT/SGPT NNP B-NP O
18 CD I-NP O
AST/SGOT NNP B-NP O
35( CD I-NP O
H) . O O
ALKP NNP B-NP O
101( CD I-NP O
H) . O O
ABG . O O
11/16/77 CD O B-DATE
11:41 CD O O
TEMP NNP B-NP O
40.9 CD I-NP O
FIO2 CD B-NP O
.98 CD I-NP O
aPO2 IN B-PP O
166( CD B-NP O
H) . O O
aPCO2 NN B-NP O
40 CD I-NP O
aPH RB B-NP O
7.48( CD I-NP O
H) . O O
UBASEX NNP B-NP O
5.7 CD I-NP O
NA-PL NNP B-NP O
140 CD I-NP O
11/16/77 CD O B-DATE
05 CD B-NP O
:05 CD I-NP O
11/16/77 CD B-NP B-DATE
11/16/77 CD I-NP B-DATE
11/16/77 CD I-NP B-DATE
11/15/77 CD O B-DATE
14:24 CD B-NP O
10:15 CD I-NP O
05 CD I-NP O
:05 IN B-PP O
03 CD B-NP O
:58 CD I-NP O
CK NNP B-NP O
984( CD I-NP O
H) . O O
946( CD B-NP O
H) NN I-NP O
573( CD B-NP O
H) NN I-NP O
536( CD B-NP O
H) NN I-NP O
CK-MB NNP B-NP O
4.8 CD I-NP O
5.2 CD I-NP O
4.5 CD O O
CKMBRI NNP B-NP O
see VBP B-VP O
detail NN B-NP O
0.5 CD I-NP O
see VBP B-VP O
detail NN B-NP O
TROP-T NN B-NP O
0.27( CD I-NP O
H) NNP B-NP O
0.21( CD I-NP O
H) . O O
0.02 CD O O
11/16/77 CD B-NP B-DATE
11/16/77 CD I-NP B-DATE
11/16/77 IN B-PP B-DATE
11/15/77 CD B-NP B-DATE
11/15/77 CD I-NP B-DATE
14:24 CD B-NP O
11:41 CD I-NP O
05 CD I-NP O
:05 IN B-PP O
22:03 CD B-NP O
03 CD I-NP O
:58 . O O
WBC . O O
11.1( CD B-NP O
H) NN I-NP O
15.3( CD B-NP O
H) NN I-NP O
17.8( CD B-NP O
H) NN I-NP O
11.4( CD B-NP O
H) NN I-NP O
RBC NNP B-NP O
3.31( JJ I-NP O
L NNP I-NP O
) -RRB- O O
3.53( JJ B-NP O
L NNP I-NP O
) -RRB- O O
3.59( JJ B-NP O
L NNP I-NP O
) -RRB- O O
2.54( JJ B-NP O
L NNP I-NP O
) -RRB- O O
HGB NN B-NP O
9.6( JJ B-NP O
L NNP I-NP O
) -RRB- I-NP O
9.9( JJ I-NP O
L NNP I-NP O
) -RRB- I-NP O
10.3( JJ I-NP O
L NNP I-NP O
) -RRB- O O
10.8( JJ B-NP O
L NNP I-NP O
) -RRB- O O
7.5( JJ B-NP O
L NNP I-NP O
) -RRB- O O
HCT NNP B-NP O
27.7( JJ I-NP O
L NNP I-NP O
) -RRB- O O
29.3( JJ B-NP O
L NNP I-NP O
) -RRB- O O
30.0( JJ B-NP O
L NNP I-NP O
) -RRB- O O
21.4( JJ B-NP O
L NNP I-NP O
) -RRB- O O
MCV . O O
84 CD B-NP O
83 CD I-NP O
84 CD I-NP O
84 CD O O
MCH . O O
28.9 CD B-NP O
29.3 CD I-NP O
30.2 CD I-NP O
29.8 CD O O
MCHC NNP B-NP O
34.5 CD I-NP O
35.3 CD I-NP O
36.0 CD I-NP O
35.2 CD O O
PLT NNP B-NP O
152 CD I-NP O
164 CD I-NP O
166 CD I-NP O
174 CD O O
RDW . O O
14.7( CD B-NP O
H) NN I-NP O
14.5 CD B-NP O
14.7( CD I-NP O
H) . O O
14.4 CD O O
DIFFR NN B-NP O
Received VBN O O
METHOD NNP B-NP O
Auto NN I-NP O
%NEUT NNP B-NP O
85( CD I-NP O
H) . O O
%LYMPH NNP B-NP O
11( JJ I-NP O
L NNP I-NP O
) -RRB- O O
%MONO NN B-NP O
4 CD I-NP O
%EOS NNS B-NP O
0 CD B-NP O
%BASO NN B-NP O
0 CD I-NP O
ANEUT NNP B-NP O
15.20( CD I-NP O
H) . O O
ALYMP NNP B-NP O
1.85 CD I-NP O
AMONS NNS B-NP O
0.63 CD B-NP O
AEOSN NNP B-NP O
0.07( JJ I-NP O
L NNP I-NP O
) -RRB- O O
ABASOP NNP B-NP O
0.03 CD I-NP O
ANISO NNP B-NP O
None NN I-NP O
HYPO NNP B-NP O
None NN I-NP O
MACRO NNP B-NP O
None NN I-NP O
MICRO NNP B-NP O
None NN I-NP O
11/16/77 CD B-NP B-DATE
11/15/77 CD I-NP B-DATE
12:11 CD B-NP O
11:09 CD I-NP O
UA-COLOR NNP B-NP O
Yellow NNP I-NP O
Yellow JJ O O
UA-APP NNP B-NP O
Clear NNP I-NP O
Clear NNP I-NP O
UA-GLUC NNP B-NP O
Negative NNP I-NP O
Trace NN B-NP O
UA-BIL NNP B-NP O
I PRP B-NP O
Negative . O O
Negative JJ O O
UA-KET NNP B-NP O
Trace NNP I-NP O
Negative . O O
UA-SPGR NNP B-NP O
1.008 CD I-NP O
1.011 CD O O
UA-BLD NNP B-NP O
3+ CD I-NP O
1+ . O O
UA-PH NNP B-NP O
5.5 CD I-NP O
7.5 CD O O
UA-PROT JJ B-NP O
1+ CD I-NP O
1+ CD O O
UA-UROBI NNP B-NP O
Negative NNP I-NP O
Negative JJ O O
UA-NIT NNP B-NP O
Negative NNP I-NP O
Negative JJ O O
UA-WBC NNP B-NP O
Negative NNP I-NP O
Negative JJ O O
UAS-RBC NNP B-NP O
&gt NNP I-NP O
;100 CD I-NP O
0-2 . O O
UAS-WBC NNP B-NP O
3-5 CD I-NP O
0-2 . O O
HCAST NNP B-NP O
10-20 CD I-NP O
0-2 . O O
GCAST NNP B-NP O
5-10 CD I-NP O
UAS-MUC NNP B-NP O
PRESENT JJ I-NP O
UAS-COM NNP B-NP O
see VBP B-VP O
detail NN B-NP O
see VBP B-VP O
detail NN B-NP O
MICROBIOLOGY NN B-NP O
Blood NN B-NP O
culture NN I-NP O
: : O O
No DT B-NP O
growth NN I-NP O
Urine JJ B-NP O
culture NN I-NP O
: : O O
No DT B-NP O
growth NN I-NP O
RADIOLOGICAL NNP B-NP O
STUDIES NNS I-NP O
CXR NN B-NP O
IMPRESSION NN B-NP O
: : O O
Bilateral JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
, , O O
more RBR B-NP O
prominent JJ I-NP O
than IN I-NP O
11/14/77 CD I-NP B-DATE
EKG . O O
Initially RB B-ADVP O
unable JJ B-ADJP O
to TO B-VP O
obtain VB I-VP O
because IN B-PP O
of IN I-PP O
pt&#8217 DT B-NP O
;s JJ I-NP O
tremor NN I-NP O
. . O O
When WRB B-ADVP O
more RBR B-NP O
calm JJ I-NP O
, , O O
EKG NNP B-NP O
was VBD B-VP O
irregular JJ B-ADJP O
, , O O
no DT B-NP O
acute JJ I-NP O
ST NNS I-NP O
or CC O O
T NNP B-NP O
wave NN I-NP O
changes NNS I-NP O
. . O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
88 CD B-NP B-AGE
yo NNP I-NP O
female NN I-NP O
with IN B-PP O
a DT B-NP O
PMH NNP I-NP O
of IN B-PP O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
severe JJ B-NP O
anxiety NN I-NP O
and CC I-NP O
history NN I-NP O
of IN B-NP O
falls VBZ B-VP O
presenting VBG I-VP O
with IN B-PP O
pubic JJ B-NP O
ramus NN I-NP O
and CC I-NP O
dens NNS I-NP O
fracture NN I-NP O
, , O O
now RB B-ADVP O
with IN B-PP O
new JJ B-NP O
fevers NNS I-NP O
, , O O
rigidity NN B-NP O
and CC I-NP O
tachycardia NN I-NP O
. . O O
ISSUE NNP B-NP O
# # I-NP O
1 CD I-NP O
: : O O
Fever NNP B-NP O
and CC I-NP O
tremors NNS I-NP O
. . O O
Differential NNP B-NP O
includes VBZ B-VP O
infection NN B-NP O
, , I-NP O
seizure NN I-NP O
, , O O
NMS NNP B-NP O
or CC O O
serotonin JJ B-NP O
syndrome NN I-NP O
. . O O
A DT B-NP O
temperature NN I-NP O
of IN B-PP O
105.6 CD B-NP O
with IN B-PP O
no DT B-NP O
obvious JJ I-NP O
infectious JJ I-NP O
source NN I-NP O
does VBZ B-VP O
make VB I-VP O
infection NN B-NP O
seem VB B-VP O
less RBR B-ADJP O
likely JJ I-ADJP O
, , O O
however RB B-ADVP O
patient NN B-NP O
will MD B-VP O
be VB I-VP O
treated VBN I-VP O
empirically RB B-ADVP O
with IN B-PP O
vancomycin NN B-NP O
, , I-NP O
ceftriaxone NN I-NP O
and CC I-NP O
levoquin NN I-NP O
for IN B-PP O
possible JJ B-NP O
hospital NN I-NP O
acquired VBD B-VP O
aspiration IN B-PP O
pneumonia NN B-NP O
or CC I-NP O
meningitis NN I-NP O
. . O O
An DT B-NP O
LP NNP I-NP O
will MD B-VP O
be VB I-VP O
attempted VBN I-VP O
if IN B-SBAR O
it PRP B-NP O
can MD B-VP O
be VB I-VP O
safely RB I-VP O
done VBN I-VP O
without IN B-PP O
compromising VBG B-VP O
the DT B-NP O
patient&#8217 NN I-NP O
;s VBD B-VP O
respiratory JJ B-NP O
status NN I-NP O
, , O O
and CC O O
in IN B-PP O
the DT B-NP O
context NN I-NP O
of IN B-PP O
the DT B-NP O
patient&#8217 NN I-NP O
;s NN I-NP O
tremor NN I-NP O
. . O O
In IN B-PP O
the DT B-NP O
context NN I-NP O
of IN B-PP O
recently RB B-VP O
receiving VBG I-VP O
Seroquel NNP B-NP O
, , I-NP O
Zyprexa NNP I-NP O
and CC I-NP O
Fluoxetine NNP I-NP O
, , O O
it PRP B-NP O
is VBZ B-VP O
also RB B-ADVP O
possible JJ B-ADJP O
that IN B-SBAR O
patient NN B-NP O
could MD B-VP O
have VB I-VP O
either DT B-NP O
serotonin NN I-NP O
syndrome NN I-NP O
or CC O O
neuroleptic JJ B-NP O
malignant JJ I-NP O
syndrome NN I-NP O
, , O O
which WDT B-NP O
could MD B-VP O
explain VB I-VP O
the DT B-NP O
patient&#8217 NN I-NP O
;s VBZ B-VP O
elevated VBN I-VP O
CK NNP B-NP O
, , O O
elevated VBD B-VP O
WBC NNP B-NP O
, , O O
elevated VBD B-VP O
LFTs NNP B-NP O
, , O O
extremely RB B-NP O
high JJ I-NP O
temperature NN I-NP O
and CC I-NP O
tremor NN I-NP O
with IN B-PP O
rigidity NN B-NP O
. . O O
Continue NNP B-NP O
to TO B-VP O
follow VB I-VP O
lytes NNS B-NP O
, , O O
CK NNP B-NP O
, , O O
CBC NNP B-NP O
Small JJ B-NP O
doses NNS I-NP O
of IN B-PP O
Ativan NNP B-NP O
for IN B-PP O
tremor/anxiety NN B-NP O
AVOID NNP B-NP O
all DT I-NP O
neuroleptics NNS I-NP O
(typical JJ I-NP O
and CC I-NP O
atypical JJ I-NP O
) -RRB- O O
Continue NNP B-NP O
antibiotics NNS I-NP O
, , O O
F/U NNP B-NP O
cultures NNS I-NP O
ISSUE NNP B-NP O
# # I-NP O
2 CD I-NP O
: : O O
Type NNP B-NP O
III NNP I-NP O
Dens NNP I-NP O
fracture NN I-NP O
and CC I-NP O
pubic JJ I-NP O
rami NNS I-NP O
fracture NN I-NP O
. . O O
Keep VB B-VP O
in IN B-PP O
C NNP B-NP O
collar NN I-NP O
, , O O
manage VB B-VP O
rami NNS B-NP O
fracture NN I-NP O
medically RB B-LST O
ISSUE NNP B-NP O
# # I-NP O
3 CD I-NP O
: : O O
DM. NNP B-NP O
Continue NNP I-NP O
FSGs NNP I-NP O
and CC O O
RISS. NNP B-NP O
ISSUE NNP B-NP O
# # I-NP O
4 CD I-NP O
: : O O
Anemia NNP B-NP O
. . I-NP O
Continue NNP I-NP O
to TO B-VP O
follow VB I-VP O
Hct NNP B-NP O
and CC O O
monitor VB B-VP O
hematoma NN B-NP O
on IN B-PP O
R NN B-NP O
thigh NN I-NP O
PROPYLAXIS NNS B-NP O
DVT NNP B-NP O
: : O O
Teds NNS B-NP O
, , O O
Pneumoboots NNS B-NP O
BOWEL NNP B-NP O
: : O O
Colace NNP B-NP O
, , O O
Senna NNP B-NP O
prn NN I-NP O
CODE NNP B-NP O
: : O O
Full JJ B-NP O
code NN I-NP O
( -LRB- I-NP O
discussion NN I-NP O
continuing VBG B-VP O
with IN B-PP O
family NN B-NP O
) -RRB- O O
Krystal NNP B-NP B-DOCTOR
Eddy NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
, , O O
PhD NNP B-NP O
Pager NNP B-NP O
# # I-NP O
29676 CD O B-PHONE
